Econavista (TSE:5585) EBITDA Margin % : 38.45% (As of Jan. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Econavista EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Econavista's EBITDA for the three months ended in Jan. 2024 was 円133.4 Mil. Econavista's Revenue for the three months ended in Jan. 2024 was 円346.8 Mil. Therefore, Econavista's EBITDA margin for the quarter that ended in Jan. 2024 was 38.45%.

Econavista EBITDA Margin % Historical Data

The historical data trend for Econavista's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Econavista EBITDA Margin % Chart

Econavista Annual Data

Trend

Oct21

Oct22

Oct23

EBITDA Margin %

27.06

36.71

37.88

Econavista Quarterly Data
	Oct21	Oct22	Apr23	Jul23	Oct23	Jan24
EBITDA Margin %	Get a 7-Day Free Trial			-	-	3.75	-37.60	38.45

Competitive Comparison of Econavista's EBITDA Margin %

For the Health Information Services subindustry, Econavista's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Econavista's EBITDA Margin % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Econavista's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Econavista's EBITDA Margin % falls into.

Econavista EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Econavista's EBITDA Margin % for the fiscal year that ended in Oct. 2023 is calculated as

EBITDA Margin %	=	EBITDA (A: Oct. 2023 )	/	Revenue (A: Oct. 2023 )
	=	411.495	/	1086.242
	=	37.88 %

Econavista's EBITDA Margin % for the quarter that ended in Jan. 2024 is calculated as

EBITDA Margin %	=	EBITDA (Q: Jan. 2024 )	/	Revenue (Q: Jan. 2024 )
	=	133.363	/	346.806
	=	38.45 %

Econavista (TSE:5585) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Econavista EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Econavista's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Econavista (TSE:5585) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Econavista Inc (TSE:5585) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

3-1 Kioicho, KKD Building 6 Floor, Chiyoda-ku, Tokyo, JPN, 102-0094

Website

https://www.econavista.com

Econavista Inc is engaged in the Development of AI for predicting health status transition through sleep analysis technology and its application to solve social challenges, such as its AI-backed services of Life Rhythm Navi. It automatically records your daily living conditions (life rhythm) and works with specialized medical institutions to visualize the signs of dementia and diseases that are common among the elderly (heat stroke, sleep disorders, etc.). It is a monitoring system to prevent sudden changes in physical conditions and accidents in preventive medicine.

Econavista (TSE:5585) Headlines

No Headlines